Auro Packaging, LLC

FDA Regulatory Profile

Auro Packaging, LLC has 0 FDA recalls, 2 inspections, 0 510(k) clearances and 0 compliance actions on record.

Latest inspection
Jul 22, 2025 · NAI

Newer recall under related name Aurobindo Pharma Usa: Jul 23, 2026, D-0733-2026.

Reviewing Auro Packaging, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Auro Packaging, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections2Nov 9, 2026Newest record Oct 28, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Related names

NameRecalls510(k)InspectionsComplianceMost recent recall
Aurobindo Pharma Usa
Same company group
59050Jul 23, 2026 (D-0733-2026)
Aurolife Pharma
Same company group
140111May 18, 2023 (D-0877-2023)
Auromedics Pharma
Same company group
36000Sep 30, 2022 (D-0020-2023)
Aurobindo Pharma
Same company group
30120Feb 2, 2018 (D-0427-2018)
Aurobindo Pharma Limited
Same company group
00201—
Eugia Pharma Specialities Limited
Same company group
00152—
Apl Healthcare Limited
Same company group
0070—
Acrotech Biopharma
Same company group
0020—

Recent FDA Inspections

DateSiteProductClassificationFEI
Jul 22, 2025East Windsor, NJDrugsNo Action Indicated (NAI)3014026025
Aug 4, 2020East Windsor, NJDrugsNo Action Indicated (NAI)3014026025

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3014026025East Windsor, NJ2Jul 22, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.